MTA1 upregulation enhances stemness and chemoresistance of gastric cancer cells

MTA1 enhances chemoresistance and stemness in gastric cancer cells by modulating apoptosis and stemness-related proteins. It may serve as a novel therapeutic target for personalized GC treatment.

Authors

Institutions

Publication Details

Journal
Translational Oncology
Published
2025-11-10
DOI
https://doi.org/10.1016/j.tranon.2025.102583
Primary Topic
Histone Deacetylase Inhibitors Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MTA1 upregulation enhances stemness and chemoresistance of gastric cancer cells

Xianzhong Liu, Xin Huang, Hai Zhou
Translational Oncology
Histone Deacetylase Inhibitors Research
article

MTA1 upregulation enhances stemness and chemoresistance of gastric cancer cells

Xianzhong Liu, Xin Huang, Hai Zhou
article en

Abstract

MTA1 enhances chemoresistance and stemness in gastric cancer cells by modulating apoptosis and stemness-related proteins. It may serve as a novel therapeutic target for personalized GC treatment.

Translational OncologyVol. 63
Nanjing Second Hospital (CN)
Openalex Percentile: Top 70%
Histone Deacetylase Inhibitors Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

MTA1 upregulation enhances stemness and chemoresistance of gastric cancer cells — Xianzhong Liu, Xin Huang, et al. · Translational Oncology (2025) | TGRS Research Map | TGRS